Loading data
BNTCNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 23.39 m USD | 18.33 m USD | 15.61 m USD | 12.77 m USD | 11.27 m USD |
| Operating profit | -51.19 m USD | -41.77 m USD | -22.49 m USD | -19.08 m USD | -17.85 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -45.67 m USD | -37.86 m USD | -21.81 m USD | -14.9 m USD | -18.21 m USD |
| Net income attributable to common shareholders | -45.55 m USD | -37.92 m USD | -22.37 m USD | -19.56 m USD | — |
| Basic earnings per share | -0.98 USD/share | -1.05 USD/share | -1.22 USD/share | -14.12 USD/share | -37.88 USD/share |
| Diluted earnings per share | -0.98 USD/share | -1.05 USD/share | -1.22 USD/share | -14.12 USD/share | -37.88 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.